Global Fc Fusion Protein Market Size to Reach USD 88.68 Billion in 2032 | Emergen Research
October 18, 2023 10:36 ET
|
Emergen Research
Vancouver, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Current Market Scenario: The global Fc fusion protein market size reached USD 26.97 Billion in 2020 and is expected to register a significantly...
US and EUCAN Digital Marketing Metrics and Trends in Type 2 Diabetes, 2023 Study - Novo Nordisk's Ozempic.com Achieved the Highest Total Traffic Across T2D Patient Brand Sites in the US
October 18, 2023 03:58 ET
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Digital Marketing Trends in Type 2 Diabetes" report has been added to ResearchAndMarkets.com's offering. This report assesses key digital marketing...
Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Medicine Program
October 16, 2023 11:00 ET
|
Castle Connolly Private Health Partners
Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Program
Global Diabetes Diagnostics Market Research Report 2023-2030 - High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
October 09, 2023 03:28 ET
|
Research and Markets
Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Diabetes Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Diabetes Diagnostics Market...
Structure Therapeutics Announces $300 Million Private Placement Equity Financing
September 29, 2023 07:32 ET
|
Structure Therapeutics Inc.
$300 million financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds, along with existing cash, cash equivalents...
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
September 29, 2023 07:30 ET
|
Structure Therapeutics Inc.
GSBR-1290 shown to be generally well-tolerated with no adverse event-related discontinuations in Phase 1b multiple ascending dose study Significant weight loss at 28 days supporting once-daily...
Acute Pancreatitis Market worth $8.82 Billion by 2030 - Exclusive Report by The Insight Partners
September 18, 2023 09:10 ET
|
The Insight Partners
Pune, India, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Acute pancreatitis is a condition characterized by the inflammation of pancreas over a short period. It is a common disease and a leading cause of...
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
September 18, 2023 05:59 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding...
Interchangeable Biosimilars Market revenue to hit USD 65 Billion by 2035, says Research Nester
September 11, 2023 07:00 ET
|
Research Nester
New York, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The global Interchangeable Biosimilars market size is slated to expand at ~ 20 % CAGR between 2023 and 2035. The market is poised to garner a revenue of...
Point of Care Diagnostics Market is Expected to Reach $75.5 billion | MarketsandMarkets.
August 30, 2023 09:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 30, 2023 (GLOBE NEWSWIRE) -- In the near future, the Point of Care Diagnostics industry is poised to undergo transformative advancements, revolutionizing healthcare by enabling rapid,...